Clinical Trials Search
Clinical Trial 21042
Cancer Type: Breast
Study Type: Treatment
NCT#: NCT03199885
Phase: Phase III
Principal Investigator:
Study Title
A Randomized, Double-Blind, Phase III Trial of Paclitaxel/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
Summary
Objective
Therapies
Medications
If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.